Status:
UNKNOWN
Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
Lead Sponsor:
National University Hospital, Singapore
Conditions:
Cervical Cancer
Cervical Dysplasia
Eligibility:
FEMALE
30-69 years
Phase:
NA
Brief Summary
In Singapore, the current cervical cancer screening uptake among women in Singapore has remained at low 50% since its introduction in 2004. It has been widely reported that under-screened women have t...
Detailed Description
Cervical cancer is one of the leading causes of death worldwide. The recognition that cervical cancer is caused by persistent oncogenic HPV virus has caused a considerable paradigm shift in screening ...
Eligibility Criteria
Inclusion
- Inclusion criteria: All women aged between 30-69 years who are attending clinics in NUH.
- Exclusion criteria:
- Women who are pregnant
- Previous total hysterectomy
- Previous history of cervical cancer
- Virgin Intacto
- Negative Pap smear less than 3 years ago.
Exclusion
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03813576
Start Date
March 1 2019
End Date
December 1 2019
Last Update
January 23 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.